Published in Gut on July 01, 1988
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Five years of GWAS discovery. Am J Hum Genet (2012) 12.97
Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genet (2007) 3.29
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology (2007) 2.97
Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol (2006) 2.93
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut (1993) 2.35
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science (2016) 2.22
Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ (2009) 2.22
Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol (2012) 2.17
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut (1999) 2.01
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
The genetics of inflammatory bowel disease. Gut (1997) 1.83
Inflammatory bowel disease: past, present, and future. J Gastroenterol (2007) 1.83
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A (2009) 1.75
Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS One (2007) 1.57
Antibiotic use and the development of Crohn's disease. Gut (2004) 1.56
Family and twin studies in inflammatory bowel disease. World J Gastroenterol (2006) 1.54
Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent. Gut (1999) 1.53
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 1.44
Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg (2010) 1.41
Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol (2011) 1.38
Synthetic associations in the context of genome-wide association scan signals. Hum Mol Genet (2010) 1.36
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ (1993) 1.34
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut (2003) 1.31
A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A (2001) 1.30
Pre-illness dietary factors in inflammatory bowel disease. Gut (1997) 1.29
MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet (2003) 1.26
Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Cytokine gene polymorphisms in inflammatory bowel disease. Gut (1996) 1.21
The genetic jigsaw of inflammatory bowel disease. Gut (2002) 1.20
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A (2001) 1.17
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut (2004) 1.17
Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet (1998) 1.17
Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin Exp Immunol (1992) 1.16
Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol (2007) 1.12
Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum Mol Genet (2014) 1.10
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet (2011) 1.10
Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut (1999) 1.09
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol (2013) 1.06
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06
Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One (2014) 1.04
Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect (2007) 1.03
Inflammatory bowel disease: genetic and epidemiologic considerations. World J Gastroenterol (2008) 1.03
Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One (2011) 1.03
Analysis of the genetic basis of disease in the context of worldwide human relationships and migration. PLoS Genet (2013) 1.01
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet (2000) 1.01
Association of linear growth impairment in pediatric Crohn's disease and a known height locus: a pilot study. Ann Hum Genet (2010) 1.01
Inflammatory bowel disease. Arch Dis Child (2006) 1.00
Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet (1996) 0.99
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung (2008) 0.98
Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol (1998) 0.98
Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm (2004) 0.97
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut (2005) 0.97
Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol (2003) 0.97
Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol (2005) 0.97
Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping. PLoS One (2015) 0.96
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut (2006) 0.94
CARD4/NOD1 is not involved in inflammatory bowel disease. Gut (2003) 0.94
IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut (1992) 0.94
Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy? World J Stem Cells (2015) 0.93
The history of genetics in inflammatory bowel disease. Ann Gastroenterol (2014) 0.92
Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease. PLoS One (2009) 0.91
Presymptomatic risk assessment for chronic non-communicable diseases. PLoS One (2010) 0.90
Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease. Gut (1995) 0.90
Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. Am J Hum Genet (2011) 0.90
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut (2001) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis (2015) 0.87
Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives. Clin Exp Immunol (1998) 0.86
Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol (2011) 0.85
Crohn's disease: the genetic contribution. Gut (1993) 0.84
Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol (2009) 0.84
Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Dig Dis Sci (2001) 0.83
Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 0.83
The ulcerative colitis marker protein WAFL interacts with accessory proteins in endocytosis. Int J Biol Sci (2010) 0.83
Elevated basal intestinal mucosal cytokine levels in asymptomatic first-degree relatives of patients with Crohn's disease. World J Gastroenterol (2000) 0.83
Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr (2015) 0.83
1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci (2008) 0.82
P-ANCA in monozygotic twins with inflammatory bowel disease. Gut (1995) 0.82
Protein tyrosine phosphatase σ targets apical junction complex proteins in the intestine and regulates epithelial permeability. Proc Natl Acad Sci U S A (2014) 0.82
Genetics of inflammatory bowel disease: current status and future directions. Can J Gastroenterol (2006) 0.82
Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data. Am J Hum Genet (2016) 0.82
Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol (1998) 0.81
OCTNs: will the real IBD5 gene please stand up? World J Gastroenterol (2006) 0.81
Identification of a new WASP and FKBP-like (WAFL) protein in inflammatory bowel disease: a potential marker gene for ulcerative colitis. Int J Colorectal Dis (2008) 0.81
Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature. Case Rep Dent (2015) 0.80
The outcome of Crohn's disease. Br J Surg (1965) 3.83
Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology (1982) 3.28
Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet Stat Med (1961) 2.61
Concordance in twins: methods and interpretation. Am J Hum Genet (1974) 2.45
Heritability of liability and concordance in monozygous twins. Ann Hum Genet (1970) 2.35
Smoking and Crohn's disease. Br Med J (Clin Res Ed) (1984) 2.17
FAMILIAL OCCURRENCE OF REGIONAL ENTERITIS AND ULCERATIVE COLITIS. Gastroenterology (1963) 2.06
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Epidemiology of inflammatory bowel disease. Epidemiol Rev (1986) 1.84
Smoking and inflammatory bowel disease. A case control study. Gut (1988) 1.69
A genetic study of ulcerative colitis. Scand J Gastroenterol (1966) 1.42
Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology (1984) 1.36
Protein abnormalities in ulcerative colitis patients and their families. Gastroenterology (1963) 1.30
Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol (1987) 1.30
Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry (1983) 1.28
Chronic regional enterocolitis (mb Crohn) in children and adolescents. Acta Paediatr Scand (1971) 1.18
The occurrence of chronic ulcerative colitis in twin males. Gastroenterology (1950) 1.14
[Regional ileitis in female twins]. Gastroenterologia (1958) 1.07
Ulcerative colitis in female monozygotic twins and a female sibling. Gastroenterology (1971) 1.06
Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency. N Engl J Med (1967) 1.05
Genetic implications in ulcerative colitis. Am Surg (1971) 1.01
Ulcerative colitis in children. Am J Psychiatry (1962) 1.01
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00
Monozygotic twins with ulcerative colitis. Postgrad Med J (1982) 1.00
Genetic tendency in Crohn's disease. Gut (1969) 0.98
[Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis]. Dtsch Med Wochenschr (1984) 0.97
Monozygotic twins with Crohn's disease: a case report. Gastroenterology (1980) 0.96
Ileojejunitis in a pair of identical twins. Gastroenterology (1976) 0.95
Perianal Paget's disease. Proc R Soc Med (1971) 0.94
Crohn's disease in monozygotic twins. Acta Chir Scand (1972) 0.93
[Crohn disease in univitelline twins]. An Esp Pediatr (1983) 0.93
[Regional enteritis in monozygotic twins. Report of an 11th case and review of the literature (author's transl)]. Gastroenterol Clin Biol (1977) 0.92
Monozygotic triplets with Crohn's disease of the colon. Gastroenterology (1986) 0.92
Discordance for ulcerative colitis in identical twins concordant for cholestatic liver disease. Report of 2 cases. Am J Dig Dis (1970) 0.91
Twin concordance. A more general model. Acta Genet Med Gemellol (Roma) (1979) 0.90
[Familial occurrence of Crohn's regional enteritis in binovular twins and 2 other siblings]. Munch Med Wochenschr (1972) 0.89
Discordant occurrence of ulcerative colitis in identical twins. Gastroenterology (1973) 0.89
[Crohn disease in monozygotic twins: description of a new case and review of the literature]. Rev Esp Enferm Apar Dig (1985) 0.88
Concordance of arthritis and iritis in identical twins with ulcerative colitis. J Natl Med Assoc (1974) 0.88
[CROHN'S ILEITIS IN UNIVITELLINE TWINS]. Acta Genet Med Gemellol (Roma) (1963) 0.88
Identical twins concordant for Crohn's disease. J Clin Gastroenterol (1986) 0.88
A familial pattern in inflammatory disease of the bowel (Crohn's disease and ulcerative colitis). Dis Colon Rectum (1978) 0.87
[Crohn's disease in monozygotic twits (author's transl)]. Cesk Gastroenterol Vyz (1977) 0.87
[Clinical aspects of Crohn's disease. Report of experience at the Munich surgical university hospital 1954-1974]. MMW Munch Med Wochenschr (1975) 0.87
[Regional ileitis in univitelline twins]. Arch Mal Appar Dig Mal Nutr (1961) 0.87
Regional ileitis in children. J Mt Sinai Hosp N Y (1956) 0.86
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut (2004) 2.48
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther (2010) 2.47
Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut (1999) 2.01
Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut (1993) 1.99
Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology (1991) 1.93
Smoking in Crohn's disease: effect on localisation and clinical course. Gut (1992) 1.87
Insomnia in men-a 10-year prospective population based study. Sleep (2001) 1.81
Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology (1986) 1.80
Smoking and inflammatory bowel disease. A case control study. Gut (1988) 1.69
Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut (1995) 1.64
Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density. Scand J Gastroenterol (1999) 1.56
Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut (2004) 1.56
Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol (1991) 1.50
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals. J Clin Pathol (1981) 1.49
A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology (1982) 1.46
Assessment of renal function in workers previously exposed to cadmium. Br J Ind Med (1985) 1.43
Trainee anaesthetists understand their work in different ways: implications for specialist education. Br J Anaesth (2004) 1.43
Intensive intravenous treatment of ulcerative colitis. Gastroenterology (1985) 1.43
Adult coeliac disease within a defined geographic area in Sweden. A study of prevalence and associated diseases. Scand J Gastroenterol (1988) 1.42
The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med (2000) 1.40
[Restless legs. A much neglected syndrome]. Lakartidningen (1999) 1.39
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol (1995) 1.36
Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med (2001) 1.33
Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol (1992) 1.32
Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J (2004) 1.30
Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology (1991) 1.27
beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses. Am J Ind Med (1985) 1.23
Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy. Gut (1986) 1.20
Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol (1994) 1.18
Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut (2004) 1.13
Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy. Scand J Gastroenterol (1983) 1.10
Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol (1983) 1.10
Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol (1985) 1.08
Colchicine treatment of primary sclerosing cholangitis. Gastroenterology (1995) 1.07
Endoscopic treatment of anastomotic strictures in Crohn's disease. Endoscopy (1991) 1.06
Heterogeneity of Campylobacter pylori as demonstrated by co-agglutination testing with rabbit antibodies. Scand J Gastroenterol Suppl (1988) 1.05
Collagenous and lymphocytic colitis: a clinical and histopathological review. Can J Gastroenterol (2000) 1.05
Autoantibodies and immunoglobulins in collagenous colitis. Gut (1996) 0.99
What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med (2000) 0.98
Prevalence and incidence of respiratory symptoms in relation to indoor dampness: the RHINE study. Thorax (2006) 0.98
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut (2005) 0.97
Chrome plating: symptoms, findings in the upper airways, and effects on lung function. Arch Environ Health (1984) 0.96
Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. Scand J Gastroenterol (1981) 0.95
Sulphasalazine treatment during breast feeding. Scand J Gastroenterol (1979) 0.95
Demonstration of fluid channels in human dura and their relationship to age and intradural bleeding. Childs Nerv Syst (2009) 0.95
Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut (2006) 0.94
Hermansky-Pudlak syndrome with colitis and pulmonary fibrosis. Scand J Gastroenterol (1999) 0.94
Has smoking changed the epidemiology of ulcerative colitis? Scand J Gastroenterol (1992) 0.94
Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus. Clin Exp Allergy (2007) 0.94
Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol (2002) 0.94
IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut (1992) 0.94
Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax (2002) 0.94
The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion. Acta Med Scand (1975) 0.93
A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol (1999) 0.93
Optimum dose of olsalazine for maintaining remission in ulcerative colitis. Gut (1994) 0.92
Asthma symptoms and nasal congestion as independent risk factors for insomnia in a general population: results from the GA(2)LEN survey. Allergy (2012) 0.92
Fertility, sterility, and pregnancy in chronic inflammatory bowel disease. Scand J Gastroenterol (1982) 0.92
Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J (2002) 0.92
Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Intern Med (2004) 0.91
Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol (1993) 0.91
Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology (1999) 0.90
Same-day upper and lower endoscopy in patients with occult bleeding, melena, hematochezia, and/or microcytic anemia. A retrospective study of 224 patients. Scand J Gastroenterol (1993) 0.90
Long-term follow-up of patients with obstructive sleep apnea treated with uvulopalatopharyngoplasty. Arch Otolaryngol Head Neck Surg (1997) 0.90
Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J (2008) 0.89
Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest (1997) 0.88
A new Swedish twin registry containing environmental and medical base line data from about 14,000 same-sexed pairs born 1926-58. Acta Med Scand Suppl (1976) 0.88
Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand (1987) 0.87
Urinary excretion of proteins in chromeplaters, exchromeplaters and referents. Scand J Work Environ Health (1983) 0.87
The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Med Scand (1975) 0.87
Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol (1981) 0.87
Prevalence of Campylobacter pylori in an unselected Swedish population of patients referred for gastroscopy. Scand J Gastroenterol (1988) 0.86
Orientation in buildings: effects of familiarity, visual access, and orientation aids. J Appl Psychol (1983) 0.85
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol (2001) 0.85
Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol (1983) 0.85
Laparoscopic appendectomy in patients with refractory ulcerative colitis. Gastroenterology (2001) 0.85
Effects of betamethasone on serum iodothyronines and thyroid hormone-binding proteins in Graves' disease. Acta Med Scand (1986) 0.85
Faecal stream diversion in patients with collagenous colitis. Gut (1996) 0.84
High circulating immunoglobulin A levels in infants are associated with intestinal toxigenic Staphylococcus aureus and a lower frequency of eczema. Clin Exp Allergy (2009) 0.84
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial. Circulation (2000) 0.84
Surface properties, connective tissue protein binding and Shiga-like toxin production of Escherichia coli isolated from patients with ulcerative colitis. Zentralbl Bakteriol (1992) 0.83
Three rapid immunoassays for the determination of creatine kinase MB: an analytical, clinical, and interpretive evaluation. Am Heart J (1991) 0.83
Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand J Gastroenterol (1995) 0.83
Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol (1981) 0.82
P-ANCA in monozygotic twins with inflammatory bowel disease. Gut (1995) 0.82
Small bowel biopsy in Swedish paediatric clinics. Acta Paediatr (2002) 0.82
Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand J Gastroenterol (2003) 0.82
A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations. Gastroenterology (1982) 0.82
Acquisition of different types of locational information in cognitive maps: automatic or effortful processing? Psychol Res (1983) 0.82
In vitro effects of sulphasalazine, azodisal sodium, and their metabolites on Clostridium difficile and some other faecal bacteria. Scand J Gastroenterol (1985) 0.81
Monitoring exposure to chromic acid in chromeplating by measuring chromium in urine. Scand J Work Environ Health (1983) 0.81